CAS: 143703-25-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CE3F4 REF: AN-AG01E23XCAS: 143703-25-7 | ≥98%(HPLC) | A consultar | Mar 21 May 24 |
 | CE3F4 REF: TM-T12616LCAS: 143703-25-7 | 97.15% | 56,00 €~273,00 € | Mar 21 May 24 |
 | CE 3F4 REF: 3D-TFA70325CAS: 143703-25-7 | Min. 95% | A consultar | Lun 01 Jul 24 |
Ref: AN-AG01E23X
| 5mg | 176,00 € | |
| 10mg | 225,00 € | |
| 25mg | 485,00 € | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
CE3F4
CAS:143703-25-7
CE3F4 is a selective antagonist of exchange protein directly activated by cAMP (Epac1; IC50s of …
Fórmula:
C11H10Br2FNO
Pureza:
97.15%
Forma y color:
Solid
Peso molecular:
351.01
Ref: TM-T12616L
| 5mg | 56,00 € | |
| 10mg | 91,00 € | |
| 25mg | 151,00 € | |
| 50mg | 273,00 € | |
| 1ml*10 (DMSO) | 56,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
CE 3F4
CAS:143703-25-7
CE 3F4 is a proarrhythmic agent that activates the mitochondria and increases the levels of …
Fórmula:
C11H10Br2FNO
Pureza:
Min. 95%
Peso molecular:
351.01 g/mol
Ref: 3D-TFA70325
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 1 de Julio de 2024
